Stay up to date with our newsletter

Get in touch!

To explore career opportunities with Sai Life Sciences, share your CV here.

Lets start the conversation!

Sign up to our newsletter

Thank you!
We will be in touch shortly.

2019.06.26

Sai’s new production block

Sai’s new production block now open for business!

The brand-new API and Intermediate manufacturing facility (Block #8) at Sai Life Sciences is the company’s largest block in terms of volume and size. It marks a 70% increase in reactor volume taking the combined capacity past 400 KL.  The project was completed in an accelerated time-frame of 15 months and had the distinction of clocking 0.5 million manhours of project execution without a single lost time incident!

In addition to the increased volumetric capacity, Block #8 provides the flexibility to handle low and high volumes in a single block with 32 reactors (16 production trains) of sizes ranging from 1 KL to 10 KL. It has next generation automation, advanced containment systems, a separate storage area for staging of raw material and intermediates, an increased ratio of filter dryers to reactors ratio, a dedicated vacuum system for every two reactors, and a 5 KL cryo reactor.

Share article

More News

2025.11.27

India is evolving from being a tactical supplier to a strategic partner to global pharma

Krishna Kanumuri, MD & CEO of Sai Life Sciences, was recently interviewed by Pharmaceutical Executive for its feature on next-generation CDMOs. In the interview, he shares insights on how Indian CDMOs are evolving from tactical suppliers to strategic partners, the shifting global supply-chain landscape, and how Sai Life Sciences is preparing for the opportunities and […]
Read more

2025.11.27

Decoding the Signals of Life: CDFD’s Dr. Rashna Bhandari visits Sai

Dr. Rashna Bhandari, Principal Investigator at the Centre for DNA Fingerprinting and Diagnostics (CDFD), Hyderabad, recently visited our Sai Life Sciences campus to deliver an insightful masterclass on “Phosphate-rich biomolecules in cell signalling.” In her session, Dr. Bhandari explored how phosphate-rich molecules act as vital messengers that regulate cellular communication and coordination. She explained how […]
Read more

2025.11.08

SLSC_Sankalp

Sai Life Sciences Launches Child Safety Awareness Program in Government Schools in Hyderabad with Sankalp

Raising awareness around child safety requires sensitivity and a collective effort to help children recognize unsafe situations and know how to respond. Guided by this purpose, Sai Life Sciences, in partnership with Sankalp NGO, has launched a Child Sexual Abuse Prevention Program across ten government schools in Gachibowli, Hyderabad. The program features two age-appropriate curriculums […]
Read more

2025.11.07

Sai Life Sciences Limited

Sai Life Sciences Limited sustains growth momentum in Q2FY26

Revenue up by 36%; EBITDA up by 43%; Net Profit up by 100% Hyderabad, November 06, 2025: Sai Life Sciences Limited (BSE: 544306 I NSE: SAILIFE), one of India’s fastest growing Contract Research, Development and Manufacturing Organizations (CRDMO) announced its financial results for the second quarter and half year ended September 2025. Financial Performance: Particulars […]
Read more

2025.11.05

Where Nature Inspires Innovation: University of Kansas Prof. Apurba Dutta visits Sai

Dr. Apurba Dutta, Associate Professor at Department of Medicinal Chemistry, University of Kansas, USA, recently visited our Sai Life Sciences campus to deliver a masterclass on “A serine-derived second-generation chiron: Applications in the synthesis of natural and nature-like molecular scaffolds.”During the session, he explored how simple natural molecules can serve as versatile building blocks for […]
Read more